ANNMARIE LALLY: Open Payments
NPI 1538205968 · TONAWANDA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$717 in 41 payments from 14 companies in 2025. Trend: 2023 $1,304 · 2024 $1,793 · 2025 $717
Food & beverage: $717
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $169 |
| Novartis Pharmaceuticals Corporation | 6 | $126 |
| Lilly USA, LLC | 4 | $72 |
| PFIZER INC. | 3 | $51 |
| Amgen Inc. | 3 | $50 |
| E.R. Squibb & Sons, L.L.C. | 3 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $44 |
| Exact Sciences Corporation | 2 | $40 |
| Phathom Pharmaceuticals, Inc. | 2 | $28 |
| Pharmacosmos Therapeutics Inc. | 1 | $27 |
Products named: LEQVIO, Ozempic, Rybelsus, MOUNJARO, CAMZYOS, Kerendia, Cologuard Collection Kit, REPATHA.
Industry payments across NY — which companies pay providers there.
